Clinical Trial Update: Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating blinatumomab in combination with reduced-dose chemotherapy for precursor B-cell acute lymphoblastic leukemia; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Precursor B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Precursor B-Cell Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING